Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
| Last: | $1.75 |
|---|---|
| Change Percent: | 3.86% |
| Open: | $1.87 |
| Close: | $1.685 |
| High: | $1.87 |
| Low: | $1.56 |
| Volume: | 1,446 |
| Last Trade Date Time: | 03/24/2026 11:41:15 am |
| Market Cap: | $18,581,874,872 |
|---|---|
| Float: | 177,467,581 |
| Insiders Ownership: | N/A |
| Institutions: | 132 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.revmed.com |
| Country: | US |
| City: | Redwood City |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Revolution Medicines Inc. Warrant (NASDAQ: RVMDW).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
